New Artificial Intelligence Tool for Automated Assessment of Liver Fat

Resonance Health is pleased to announce that it has successfully trained a neural network (artificial intelligence, ‘AI’) for the automated assessment of liver fat from MRI data.

Read more

Resonance Health Files Provisional Patent

Resonance Health is pleased to announce that it has filed a provisional patent for the discovery and use of novel blood markers to determine an individual’s iron status.  These blood markers have been identified as part of the Company’s molecular medicine R&D program. 

Read more

International Thalassaemia Day

International Thalassaemia Day is a very special day that commemorates thalassemia patients everywhere.  

Read more

Resonance Health News - April 2019

Resonance Health is delighted to provide you with our latest customer newsletter where you can find an update on all our latest acitvities.

To read the newsletter please click here

Distribution Agreement with EnvoyAI

Resonance Health is pleased to announce that it has entered into a Distribution Agreement with EnvoyAI for the distribution of the Company’s FerriSmart® product, which recently received FDA regulatory clearance.

Read more

FDA Clearance Granted for FerriSmart

Resonance Health is please to announce that it has received 510(k) clearance from the US Food and Drug Administration for FerriSmart®, the Company's ground-breaking machine learning solution for the quantification of liver iron concentration.

Read more